Immunome Inc (IMNM)
11.18
-0.76
(-6.37%)
USD |
NASDAQ |
Jun 26, 10:29
Immunome 1 Year Total Returns (Daily): 107.2% for June 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 25, 2024 | 107.2% |
| June 24, 2024 | 114.4% |
| June 21, 2024 | 119.0% |
| June 20, 2024 | 121.5% |
| June 18, 2024 | 129.4% |
| June 17, 2024 | 127.1% |
| June 14, 2024 | 182.6% |
| June 13, 2024 | 209.1% |
| June 12, 2024 | 221.9% |
| June 11, 2024 | 230.5% |
| June 10, 2024 | 237.9% |
| June 07, 2024 | 205.2% |
| June 06, 2024 | 207.3% |
| June 05, 2024 | 201.4% |
| June 04, 2024 | 168.2% |
| June 03, 2024 | 176.3% |
| May 31, 2024 | 185.1% |
| May 30, 2024 | 187.3% |
| May 29, 2024 | 185.5% |
| May 28, 2024 | 185.5% |
| May 24, 2024 | 148.2% |
| May 23, 2024 | 152.0% |
| May 22, 2024 | 182.7% |
| May 21, 2024 | 145.3% |
| May 20, 2024 | 148.0% |
| Date | Value |
|---|---|
| May 17, 2024 | 143.9% |
| May 16, 2024 | 152.2% |
| May 15, 2024 | 137.9% |
| May 14, 2024 | 115.5% |
| May 13, 2024 | 128.6% |
| May 10, 2024 | 146.0% |
| May 09, 2024 | 147.7% |
| May 08, 2024 | 172.6% |
| May 07, 2024 | 183.9% |
| May 06, 2024 | 186.3% |
| May 03, 2024 | 209.4% |
| May 02, 2024 | 189.6% |
| May 01, 2024 | 192.6% |
| April 30, 2024 | 193.5% |
| April 29, 2024 | 188.5% |
| April 26, 2024 | 159.1% |
| April 25, 2024 | 156.9% |
| April 24, 2024 | 169.2% |
| April 23, 2024 | 176.6% |
| April 22, 2024 | 188.3% |
| April 19, 2024 | 178.9% |
| April 18, 2024 | 211.8% |
| April 17, 2024 | 216.0% |
| April 16, 2024 | 281.7% |
| April 15, 2024 | 291.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.67%
Minimum
May 09 2022
531.4%
Maximum
Mar 07 2024
43.30%
Average
26.77%
Median
Oct 07 2021
1 Year Total Returns (Daily) Benchmarks
| Exelixis Inc | 12.13% |
| Ayala Pharmaceuticals Inc | -78.35% |
| CEL-SCI Corp | -46.75% |
| AIM ImmunoTech Inc | -18.82% |
| IGC Pharma Inc | 40.06% |